167 related articles for article (PubMed ID: 19131950)
1. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs.
Purdie KJ; Harwood CA; Gulati A; Chaplin T; Lambert SR; Cerio R; Kelly GP; Cazier JB; Young BD; Leigh IM; Proby CM
J Invest Dermatol; 2009 Jun; 129(6):1562-8. PubMed ID: 19131950
[TBL] [Abstract][Full Text] [Related]
2. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis.
Purdie KJ; Lambert SR; Teh MT; Chaplin T; Molloy G; Raghavan M; Kelsell DP; Leigh IM; Harwood CA; Proby CM; Young BD
Genes Chromosomes Cancer; 2007 Jul; 46(7):661-9. PubMed ID: 17420988
[TBL] [Abstract][Full Text] [Related]
3. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
4. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.
Herzog CR; Crist KA; Sabourin CL; Kelloff GJ; Boone CW; Stoner GD; You M
Mol Carcinog; 2001 Mar; 30(3):159-68. PubMed ID: 11301476
[TBL] [Abstract][Full Text] [Related]
6. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer.
Sikkink SK; Rehman I; Rees JL
J Invest Dermatol; 1997 Dec; 109(6):801-5. PubMed ID: 9406824
[TBL] [Abstract][Full Text] [Related]
8. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
Lambert SR; Harwood CA; Purdie KJ; Gulati A; Matin RN; Romanowska M; Cerio R; Kelsell DP; Leigh IM; Proby CM
Int J Cancer; 2012 Aug; 131(3):E216-26. PubMed ID: 22052591
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma.
Fleming JL; Dworkin AM; Allain DC; Fernandez S; Wei L; Peters SB; Iwenofu OH; Ridd K; Bastian BC; Toland AE
Int J Cancer; 2014 Jan; 134(1):244-8. PubMed ID: 23784969
[TBL] [Abstract][Full Text] [Related]
10. Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas.
Partridge M; Emilion G; Pateromichelakis S; Phillips E; Langdon J
Int J Cancer; 1999 Oct; 83(3):318-25. PubMed ID: 10495423
[TBL] [Abstract][Full Text] [Related]
11. [Hypermethylation of fragile histidine triad gene and 3p14 allelic deletion in ovarian carcinomas].
Hong FZ; Wang B; Li HM; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):257-61. PubMed ID: 16181544
[TBL] [Abstract][Full Text] [Related]
12. Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix.
Yoshino K; Enomoto T; Nakamura T; Nakashima R; Wada H; Saitoh J; Noda K; Murata Y
Int J Cancer; 1998 Apr; 76(2):176-81. PubMed ID: 9537577
[TBL] [Abstract][Full Text] [Related]
13. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
[TBL] [Abstract][Full Text] [Related]
14. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
15. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
[TBL] [Abstract][Full Text] [Related]
16. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
[TBL] [Abstract][Full Text] [Related]
17. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
18. Low expression of fragile histidine triad gene correlates with high proliferation in head and neck squamous cell carcinoma.
Mineta H; Miura K; Takebayashi S; Misawa K; Ueda Y; Suzuki I; Ito M; Wennerberg J
Oral Oncol; 2003 Jan; 39(1):56-63. PubMed ID: 12457722
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.
Toma MI; Grosser M; Herr A; Aust DE; Meye A; Hoefling C; Fuessel S; Wuttig D; Wirth MP; Baretton GB
Neoplasia; 2008 Jul; 10(7):634-42. PubMed ID: 18592004
[TBL] [Abstract][Full Text] [Related]
20. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
